Financial insights of OCX

MyFinsight

For the quarter ending 2025-03-31.

Income Statement	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Sales and marketing	1,206	1,100*	1,043	853
Research and development	2,924	1,934*	2,817	2,453
Impairment losses	-	10,475*	-	-
General and administrative	3,115	2,746*	2,565	2,407
Impairment loss on held for sale assets	-	-42*	-	-
Change in fair value of contingent consideration	879	18,113*	7,140	-1,031
Total operating expenses	8,124	34,410*	13,565	4,682
Net revenue	2,138	1,553*	115	104
Cost of revenues	806	941*	43	32
Cost of revenues amortization of acquired intangibles	7	22*	22	22
Gross profit	1,325	590*	50	50
Loss from operations	-6,799	-33,820*	-13,515	-4,632
Other income, net	157	218*	53	110
Interest expense	-29	-25*	-31	-8
Total other income, net	128	192*	22	102
Loss before income taxes	-6,671	-33,628	-13,493	-4,530
Net loss	-6,671	-33,628	-13,493	-4,530

Basic EPS	-0.26	-2.663	-0.98	-0.36
Diluted EPS	-0.26	-2.663	-0.98	-0.36
Basic Average Shares	25,694,000	12,629,000	13,714,000	12,870,000
Diluted Average Shares	25,694,000	12,629,000	13,714,000	12,870,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.